LaBranche & Co LAB 深 沪
已收盘 08-08 16:00:00 美东时间
1.305
+0.015
+1.16%
华盛通- 最 高1.325
- 今 开1.29
- 成交量 128.49万股
- 最 低 1.29
- 昨 收 1.29
- 总市值 4.96亿
- 52周最高 2.32
- 市盈率 静 --
- 换手率 0.34%
- 52周最低 0.92
- 委 比 4.26%
- 总股本 3.80亿
- 历史最高 49.455
- 量 比 1.39
- 振 幅 2.71%
- 历史最低 0.92
- 每 手 1
- 风险率 0.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vineet Laboratories Promoter Sells Equity Shares
An announcement from Vineet Laboratories Ltd. ( ($IN:VINEETLAB) ) is now availa...
今天 02:04
Tradr Readies Leveraged Single-Stock ETFs on ALAB and DDOG
First-to-market 2X ETFs on Astera Labs and Datadog set to trade on Tuesday NEW YORK, Aug. 8, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and prof...
08-08 21:44
WESTERN MIDSTREAM ANNOUNCES SECOND-QUARTER 2025 RESULTS
EXECUTING ON CORE GROWTH STRATEGY AND REAFFIRMING 2025 FINANCIAL GUIDANCE RANGES Reported second-quarter 2025 Net income attributable to limited partners of $333.8 million, generating record...
08-07 04:07
WESTERN MIDSTREAM TO ACQUIRE ARIS WATER SOLUTIONS
Creates a differentiated Delaware Basin produced-water system, enhancing WES's ability to compete for new business development opportunities. The combined infrastructure creates a fully inte...
08-07 04:05
Chimera Investment gives Q2 numbers
Chimera Investment press release (NYSE:CIM): Q2 GAAP EPS of $0.17. Revenue of $66M (-1.9% Y/Y). EARNINGS AVAILABLE FOR DISTRIBUTION OF $0.39 PER ADJUSTED DILUTED COMMON SHARE More on Chimera Investmen...
08-06 18:40
Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study
Standard BioTools Inc. announced that PRECISE-SG100K selected the SomaScan™ 11K Assay to run 100,000 plasma samples, advancing precision medicine. The platform's unmatched proteome coverage and reproducibility enhance large-scale proteomics research. The company has supported over 30 global biobank studies, including projects in Singapore, Norway, and the UK, driving insights into human health and disease.
08-06 11:00
中国生物制药(01177.HK)TQC3302吸入喷雾剂临床试验申请获NMPA批准
【财华社讯】中国生物制药(01177.HK)公布，集团自主研发的2.3类改良型新药TQC3302“ICS/LAMA/LABA软雾吸入制剂”吸入喷雾剂已获得中国国...
08-06 10:47
中国生物制药：TQC3302“ICS/LAMA/LABA软雾吸入制剂”临床试验申请获NMPA批准
中国生物制药(01177)发布公告，本集团自主研发的2.3类改良型新药TQC330...
08-05 18:44
Hormel Foods Corporation to Hold Third Quarter Earnings Conference Call
AUSTIN, Minn., Aug. 4, 2025 /PRNewswire/ -- Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, invites interested parties to participate in a webcast and confer...
08-05 07:09
